Inhibition of fatty acid amide hydrolase produces PPAR‐α‐mediated analgesia in a rat model of inflammatory pain
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background and purpose: We have previously demonstrated antinociceptive effects of fatty acid amide hydrolase (FAAH) inhibition that were accompanied by increases in the levels of endocannabinoids (ECs) in the hind paw. Here, the effects of the FAAH inhibitor URB597 (3′‐carbamoyl‐biphenyl‐3‐yl‐cyclohexylcarbamate) on responses of spinal neurons were studied. Experimental approach: Extracellular single‐unit recordings of dorsal horn neurons were made in anaesthetized rats with hind paw inflammation induced by λ‐carrageenan. Effects of intraplantar pre‐administration of URB597, or vehicle, on carrageenan‐evoked expansion of peripheral receptive fields of spinal neurons and mechanically evoked responses of neurons were studied. The cannabinoid receptor type 1 (CB 1) antagonist AM251 (N‐(piperidin‐1‐yl)‐5‐(4‐iodophenyl)‐1‐(2,4‐dichlorophenyl)‐4‐ methyl‐1 H‐pyrazole‐3‐carboxamide) and the peroxisome proliferator‐ activated receptor (PPAR)‐α antagonist GW6471 ([(2 S)‐2‐[[(1Z)‐1‐ methyl‐3‐oxo‐3‐[4‐(trifluoromethyl)phenyl]‐1‐propenyl]amino]‐3‐[4‐[2‐ (5‐methyl‐2‐phenyl‐4‐oxa zolyl)ethoxy]phenyl]propyl]‐carbamic acid ethyl ester) were used to investigate the roles of these receptors in mediating the effects of URB597. Key results: URB597 (25 μg in 50 μL) pretreatment significantly inhibited carrageenan‐evoked receptive field expansion and this was significantly reversed by co‐administration of the PPAR‐α antagonist but not the CB 1 antagonist. Pretreatment with the PPAR‐α receptor agonist WY14643 ([[4‐chloro‐6‐[(2,3‐dimethylphenyl)amino]‐2‐pyrimidinyl]thio]acetic acid) also significantly inhibited receptive field expansion. URB597 (25 or 100 μg in 50 μL) had no significant effect on mechanically evoked responses of spinal neurons. Conclusions and implications: URB597 inhibited receptive field expansions but not mechanically evoked responses of spinal neurons in rats with hind paw inflammation. These effects were blocked by PPAR‐α receptor antagonism. These data support the contention that URB597 exerts its antinociceptive effects by indirect inhibition of sensitization of neuronal responses at least partly through PPAR‐α activation due to enhanced EC levels. British Journal of Pharmacology (2008) 155, 1297–1306; doi:10.1038/bjp.2008.335; published online 25 August 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · cited 2×
“The endocannabinoids (ECs) anandamide (N-arachidonoylethanolamine (AEA); Devane et al., 1992) and 2-arachidonoylglycerol (2-AG; Mechoulam et al., 1995; Sugiura et al., 1995) activate cannabinoid receptor types 1 (CB1) and 2 (CB2) and have antinociceptive effects in models of acute and chronic pain…”
Background2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
The PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345 · cited 1×
“For example, PPARa activation modulates the duration of inflammation induced by leukotriene B4 (LTB4)/arachidonic acid and a direct interaction between PPAR-a and LTB4 increases the catabolism of LTB4, thus providing feedback control of inflammation (Devchand et al., 1996).”
BackgroundModulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293 · cited 3×
“…inflammationinduced hyperalgesia following peripheral administration of the FAAH inhibitor URB597 (30-carbamoyl-biphenyl-3yl-cyclohexylcarbamate) (Kathuria et al., 2003) in the carrageenan model of inflammatory pain, which was accompanied by significantly increased levels of AEA and 2-AG in the…”
BackgroundInfluentialLo Verme, J., Fu, J., Astarita, G., La Rana, G., Russo, R., Calignano, A., & Piomelli, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006353 · Cited by 882
Rapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor-α
LoVerme, J., Russo, R., La Rana, G., Fu, J., Farthing, J., Mattace-Raso, G., Meli, R., Hohmann, A., Calignano, A., & Piomelli, D. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111385 · Cited by 316 · cited 12×
“In addition to these two main enzymes, N-acylethanolamine-hydrolysing acid amidase also contributes to the metabolism of AEA and PEA (Tsuboi et al., 2007).”
BackgroundMethodResultInfluentialLichtman, A. H., Shelton, C. C., Advani, T., & Cravatt, B. F. (2004) · Pain · doi:10.1016/j.pain.2004.01.022 · Cited by 301 · cited 2×
“Our data are consistent with the well-described antinociceptive effects of FAAH inhibitors in behavioural models of inflammatory (Lichtman et al., 2004; Jayamanne et al., 2006; Jhaveri et al., 2008) and neuropathic pain (Chang et al., 2006; Jhaveri et al., 2006; Russo et al., 2007).”
BackgroundResultThe N‐Acylethanolamine‐Hydrolyzing Acid Amidase (NAAA)
Tsuboi, K., Takezaki, N., & Ueda, N. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790159 · Cited by 172 · cited 7×
“In addition to these two main enzymes, N-acylethanolamine-hydrolysing acid amidase also contributes to the metabolism of AEA and PEA (Tsuboi et al., 2007).”
BackgroundInfluentialHolt, S., Comelli, F., Costa, B., & Fowler, C. J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706348 · Cited by 168 · cited 12×
“Recent work has focused on targeting ECs and their metabolism, in preference to the use of receptor agonists, as an approach to achieving analgesia in the absence of side effects (for review, see Jhaveri et al., 2007).”
BackgroundInfluentialElmes, S. J. R., Jhaveri, M. D., Smart, D., Kendall, D. A., & Chapman, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03690.x · Cited by 160
Self-citation
Cited by
New approaches and challenges to targeting the endocannabinoid system
Di Marzo, V. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.115 · Cited by 480
The Endocannabinoid System and Pain
Guindon, J., & Hohmann, A. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824660 · Cited by 476
An update on PPAR activation by cannabinoids
O'Sullivan, S. E. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13497 · Cited by 449
Cannabinoids and Pain: New Insights From Old Molecules
Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 376
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
Clapper, J. R., Moreno-Sanz, G., Russo, R., Guijarro, A., Vacondio, F., Duranti, A., Tontini, A., Sanchini, S., Sciolino, N. R., Spradley, J. M., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2632 · Cited by 346
Chemical Probes of Endocannabinoid Metabolism
Blankman, J. L., & Cravatt, B. F. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006387 · Cited by 327
Fraguas-Sánchez, A. I., & Torres-Suárez, A. I. (2018) · Drugs · doi:10.1007/s40265-018-0996-1 · Cited by 271
The cannabinoid system and pain
Woodhams, S. G., Chapman, V., Finn, D. P., Hohmann, A. G., & Neugebauer, V. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.015 · Cited by 267
Self-citationManca, C., Boubertakh, B., Leblanc, N., Deschênes, T., Lacroix, S., Martin, C., Houde, A., Veilleux, A., Flamand, N., Muccioli, G. G., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000424 · Cited by 152
Therapeutic potential of cannabis-related drugs
Alexander, S. P. H. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.07.001 · Cited by 149
Cannabinoid Type-1 Receptor Reduces Pain and Neurotoxicity Produced by Chemotherapy
Khasabova, I. A., Khasabov, S., Paz, J., Harding-Rose, C., Simone, D. A., & Seybold, V. S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0403-12.2012 · Cited by 129
“Instead, CB2R or PPAR mediate their anti-hyperalgesic effects in other models of peripheral injury (Sagar et al., 2008; Kinsey et al., 2009).”
Background
Metadata
- Authors
- Sagar, D. R., Kendall, D. A., & Chapman, V
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-12
- Volume
- 155
- Issue
- 8
- Pages
- 1297-1306
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2034120366
- Cited by
- 89
- References
- 12
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.